Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $885 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen reiterates an Overweight rating on Eli Lilly (NYSE:LLY) and maintains a price target of $885.
August 05, 2024 | 5:53 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reiterates an Overweight rating on Eli Lilly and maintains a price target of $885.
The reiteration of an Overweight rating and a high price target of $885 by a reputable analyst is likely to positively influence investor sentiment and drive short-term price appreciation for Eli Lilly.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100